A Phase 1, Randomized, Parallel-Group, Double-Blind Trial of AV7909 (Liquid) and Thermostable AV7909 (Lyophilized) in Healthy Adult Volunteers
Latest Information Update: 24 Apr 2024
At a glance
- Drugs Anthrax vaccine adsorbed adjuvanted Emergent BioSolutions (Primary) ; Anthrax vaccine adsorbed adjuvanted Emergent BioSolutions
- Indications Anthrax
- Focus Adverse reactions
- 08 Feb 2024 Status changed from active, no longer recruiting to completed.
- 26 Oct 2023 Planned End Date changed from 4 Dec 2023 to 30 Mar 2024.
- 17 Aug 2023 Planned primary completion date changed from 7 Aug 2023 to 23 Sep 2023.